Annex
United Kingdom
The following entry shall be added at the end of the table in Annex I to Directive 91/414/EEC:
Further details on identity and specification of active substance are provided in the review report.
No Common name, identification numbers IUPAC name Purityf1 Entry into force Expiration of inclusion Specific provisions ‘108 MCPA
CAS No 94-74-6
CIPAC No 2
4-chloro-o-tolyloxyacetic acid ≥ 930 g/kg 1 May 2006 30 April 2016 PART A
Only uses as herbicide may be authorised
PART B
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on MCPA, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 15 April 2005 shall be taken into account
Member States should pay particular attention to the potential for groundwater contamination, when the active substance is applied in regions with vulnerable soil and/or climatic conditions. Conditions of authorisation should include risk mitigation measures, where appropriate
Member States must pay particular attention to the protection of aquatic organisms and must ensure that the conditions of authorisation include risk mitigation measures, where appropriate, such as buffer zones
109 MCPB
CAS No 94-81-5
CIPAC No 50
4-(4-chloro-o-tolyloxy)butyric acid ≥ 920 g/kg 1 May 2006 30 April 2016 PART A
Only uses as herbicide may be authorised
PART B
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on MCPB, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 15 April 2005 shall be taken into account
Member States should pay particular attention to the potential for groundwater contamination, when the active substance is applied in regions with vulnerable soil and/or climatic conditions. Conditions of authorisation should include risk mitigation measures, where appropriate
Member States must pay particular attention to the protection of aquatic organisms and must ensure that the conditions of authorisation include risk mitigation measures, where appropriate, such as buffer zones’
Annotations
Footnotes
- f1
-
Further details on identity and specification of active substance are provided in the review report.